Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30true2023-07-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.Manufacture of soft drinks and mineral water02truetruefalse 12470637 2023-07-01 2024-06-30 12470637 2022-07-01 2023-06-30 12470637 2024-06-30 12470637 2023-06-30 12470637 c:Director1 2023-07-01 2024-06-30 12470637 c:Director2 2023-07-01 2024-06-30 12470637 c:RegisteredOffice 2023-07-01 2024-06-30 12470637 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-06-30 12470637 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-06-30 12470637 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-06-30 12470637 d:CopyrightsPatentsTrademarksServiceOperatingRights 2023-06-30 12470637 d:CurrentFinancialInstruments 2024-06-30 12470637 d:CurrentFinancialInstruments 2023-06-30 12470637 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 12470637 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 12470637 d:ShareCapital 2024-06-30 12470637 d:ShareCapital 2023-06-30 12470637 d:RetainedEarningsAccumulatedLosses 2024-06-30 12470637 d:RetainedEarningsAccumulatedLosses 2023-06-30 12470637 c:OrdinaryShareClass1 2023-07-01 2024-06-30 12470637 c:OrdinaryShareClass1 2024-06-30 12470637 c:OrdinaryShareClass1 2023-06-30 12470637 c:FRS102 2023-07-01 2024-06-30 12470637 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 12470637 c:FullAccounts 2023-07-01 2024-06-30 12470637 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12470637 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:InternallyGeneratedIntangibleAssets 2023-07-01 2024-06-30 12470637 d:CopyrightsPatentsTrademarksServiceOperatingRights d:InternallyGeneratedIntangibleAssets 2023-07-01 2024-06-30 12470637 d:InternallyGeneratedIntangibleAssets 2023-07-01 2024-06-30 12470637 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2023-07-01 2024-06-30 12470637 d:CopyrightsPatentsTrademarksServiceOperatingRights d:OwnedIntangibleAssets 2023-07-01 2024-06-30 12470637 e:PoundSterling 2023-07-01 2024-06-30 xbrli:shares iso4217:GBP xbrli:pure


Registered number: 12470637












HEALTHY HEDONISM LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

 

HEALTHY HEDONISM LTD

CONTENTS



Page
Company information
 
1
Balance sheet
 
2 - 3
Notes to the financial statements
 
4 - 9


 

HEALTHY HEDONISM LTD
 
COMPANY INFORMATION


Directors
S S Gill 
C S Gill 




Registered number
12470637



Registered office
1 White Hart Road

Slough

Berkshire

SL1 2SF




Accountants
Blick Rothenberg Limited
Chartered Accountants

16 Great Queen Street

Covent Garden

London

WC2B 5AH




Page 1


 
REGISTERED NUMBER:12470637
HEALTHY HEDONISM LTD

BALANCE SHEET
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
36,993
23,909

  
36,993
23,909

Current assets
  

Stocks
  
28,859
-

Debtors: amounts falling due within one year
 5 
246
460

Cash at bank and in hand
  
2,262
2,689

  
31,367
3,149

Creditors: amounts falling due within one year
 6 
(251,911)
(107,907)

Net current liabilities
  
 
 
(220,544)
 
 
(104,758)

Total assets less current liabilities
  
(183,551)
(80,849)

  

Net liabilities
  
(183,551)
(80,849)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(183,651)
(80,949)

Total deficit
  
(183,551)
(80,849)


Page 2


 
REGISTERED NUMBER:12470637
HEALTHY HEDONISM LTD
    
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




C S Gill
Director

Date: 7 February 2025

The notes on pages 4 to 9 form part of these financial statements.

Page 3

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

Healthy Hedonism Ltd is a private company limited by shares incorporated in England and Wales. Its registered office is Unit 1 White Hart Road, Slough, England, SL1 2SF.
The financial statements are presented in Sterling (£), which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest Sterling (£).

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on a going concern basis notwithstanding the fact that the company has a deficiency on total equity at the end of the year. The directors consider this basis to be appropriate as the company has received a letter of support from its main creditor.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the company has transferred the significant risks and rewards of ownership to the buyer;
the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Page 4

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.5

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.


2.7

Financial instruments

The company has elected to apply Sections 11 and 12 of FRS 102 in respect of financial instruments.

Financial assets and financial liabilities are recognised when the company becomes party to the contractual provisions of the instrument. 

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. 
 
The company’s policies for its major classes of financial assets and financial liabilities are set out below. 

Financial assets
Basic financial assets, including trade and other debtors, cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Financial liabilities

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Page 5

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)





Financial instruments (continued)

Impairment of financial assets
Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account. 

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset's carrying amount and the best estimate of the amount the company would receive for the asset if it were to be sold at the reporting date. 

For financial assets measured at amortised cost, the impairment loss is measured as the difference between the asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If the financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets and financial liabilities
Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions. 
 
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Offsetting of financial assets and financial liabilities
Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

  
2.9

Share capital

Ordinary shares are classified as equity.

Page 6

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.10

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
Current tax is the amount of income tax payable in respect of taxable profit for the year or prior years.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.
Deferred tax arises from timing differences that are differences between taxable profits and total comprehensive income as stated in the financial statements. These timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in the financial statements.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


3.


Employees

The average number of employees, including directors, during the year was 2 (2023 - 2).

Page 7

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

4.


Intangible assets




Development expenditure
Trademarks
Total

£
£
£



Cost


At 1 July 2023
31,560
171
31,731


Additions
18,063
-
18,063



At 30 June 2024

49,623
171
49,794



Amortisation


At 1 July 2023
7,768
54
7,822


Charge for the year
4,962
17
4,979



At 30 June 2024

12,730
71
12,801



Net book value



At 30 June 2024
36,893
100
36,993



At 30 June 2023
23,792
117
23,909




5.


Debtors

2024
2023
£
£


Trade debtors
182
355

Other debtors
64
105

246
460


Page 8

 

HEALTHY HEDONISM LTD

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
148
66

Other taxation and social security
269
-

Other creditors
247,994
103,841

Accruals and deferred income
3,500
4,000

251,911
107,907



7.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



8.


Related party transactions

Included within other creditors is an amount of £2,443 (2023: £2,000) due to a director. This amount is interest free, unsecured and repayable on demand.
Included within other creditors is an amount of £245,551 (2023: £101,841) due to a company under common control. The loan is provided interest free and is unsecured. There are no formal terms and conditions regarding repayment of the loan.
Included within other debtors is an amount of £64 (2023: £100) due from directors. This amount is interest free, unsecured and repayable on demand.

 
Page 9